CTT Pharmaceutical Holdings, Inc. has announced the resignation of its current independent registered public accounting firm, Holt & Patterson, effective immediately. The company filed a Current Report on Form 8-K with the Securities and Exchange Commission on October 2, 2026, disclosing the change in its certifying accountant.
The filing states that there were no disagreements between the company and Holt & Patterson regarding accounting principles, practices, or financial statement disclosures. According to the report, the decision to part ways was not due to any disputes or disagreements regarding the company's accounting practices.
The company indicated that the auditor is not handling SEC reporting companies moving forward. Consequently, CTT Pharmaceutical Holdings will begin the process of searching for a new auditor. The company stated that it intends to reach out to another auditor with whom it has previously worked.
The resignation is effective as of the date of the report. The company is currently in the process of identifying and engaging a replacement firm to fulfill its audit requirements.
